Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NEUROBLASTOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05272371
What this trial is testing

Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease

Who this might be right for
High-Risk Neuroblastoma
Jagiellonian University 20
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Early research (Phase 1)Ended earlyNCT05130255
What this trial is testing

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Who this might be right for
SCLCMalignant MelanomaSarcoma+1 more
Y-mAbs Therapeutics 23
Testing effectiveness (Phase 2)Study completedNCT01114555
What this trial is testing

Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT01183884
What this trial is testing

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 46
Not applicableUnknownNCT05918432
What this trial is testing

Determining Patterns In Study Experiences of Neuroblastoma Patients

Who this might be right for
Neuroblastoma
Power Life Sciences Inc. 500
Not applicableLooking for participantsNCT06674811
What this trial is testing

Biomarkers of Resiliency In Childhood Cancer Surgery

Who this might be right for
Pediatric CancerNeuroblastomaSarcoma+10 more
Mayo Clinic 40
Large-scale testing (Phase 3)Looking for participantsNCT07549321
What this trial is testing

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

Who this might be right for
High-Risk Neuroblastoma
Renaissance Pharma Ltd. 144
Early research (Phase 1)Study completedNCT00037011
What this trial is testing

Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00407433
What this trial is testing

Clinical Studies of Gemcitabine-Oxaliplatin

Who this might be right for
MedulloblastomaCentral Nervous System TumorsNeuroblastoma+1 more
Gustave Roussy, Cancer Campus, Grand Paris 156
Early research (Phase 1)WithdrawnNCT01319838
What this trial is testing

Aflac ST1001 Prolonged Isotretinoin

Who this might be right for
Neuroblastoma
Emory University
Testing effectiveness (Phase 2)Study completedNCT01767194
What this trial is testing

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Who this might be right for
GanglioneuroblastomaRecurrent Neuroblastoma
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Study completedNCT01183429
What this trial is testing

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 39
Early research (Phase 1)Study completedNCT00112645
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
NeuroblastomaSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Milton S. Hershey Medical Center 10
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Ended earlyNCT02177773
What this trial is testing

GA-68 DOTA-TOC of Somatostatin Positive Malignancies

Who this might be right for
Neuroendocrine TumorParagangliomaCarcinoid Tumors+1 more
University of California, San Francisco 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Study completedNCT00002560
What this trial is testing

Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Early research (Phase 1)UnknownNCT05338541
What this trial is testing

Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.

Who this might be right for
Neuroblastoma in Children
Yizhuo Zhang 30
Next Page